nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylbutazone—PTGS2—ovarian follicle—ovarian cancer	0.0685	0.141	CbGeAlD
Phenylbutazone—CYP3A4—Topotecan—ovarian cancer	0.0601	0.272	CbGbCtD
Phenylbutazone—PTGIS—myometrium—ovarian cancer	0.0537	0.111	CbGeAlD
Phenylbutazone—CYP2C9—Paclitaxel—ovarian cancer	0.0512	0.232	CbGbCtD
Phenylbutazone—CYP3A4—Vinorelbine—ovarian cancer	0.0424	0.192	CbGbCtD
Phenylbutazone—PTGIS—decidua—ovarian cancer	0.0398	0.082	CbGeAlD
Phenylbutazone—PTGIS—uterus—ovarian cancer	0.0349	0.0717	CbGeAlD
Phenylbutazone—PTGS1—oviduct—ovarian cancer	0.0315	0.0647	CbGeAlD
Phenylbutazone—PTGIS—female reproductive system—ovarian cancer	0.0313	0.0645	CbGeAlD
Phenylbutazone—CYP3A4—Paclitaxel—ovarian cancer	0.0298	0.135	CbGbCtD
Phenylbutazone—PTGIS—female gonad—ovarian cancer	0.0285	0.0587	CbGeAlD
Phenylbutazone—PTGIS—testis—ovarian cancer	0.0253	0.052	CbGeAlD
Phenylbutazone—CYP3A4—Docetaxel—ovarian cancer	0.0215	0.0974	CbGbCtD
Phenylbutazone—PTGIS—lymph node—ovarian cancer	0.0183	0.0377	CbGeAlD
Phenylbutazone—SLC22A11—female reproductive system—ovarian cancer	0.0175	0.0361	CbGeAlD
Phenylbutazone—CYP3A4—Doxorubicin—ovarian cancer	0.016	0.0726	CbGbCtD
Phenylbutazone—PTGS2—myometrium—ovarian cancer	0.00962	0.0198	CbGeAlD
Phenylbutazone—PTGS2—embryo—ovarian cancer	0.00926	0.019	CbGeAlD
Phenylbutazone—PTGS1—epithelium—ovarian cancer	0.0079	0.0163	CbGeAlD
Phenylbutazone—PTGS1—uterine cervix—ovarian cancer	0.00784	0.0161	CbGeAlD
Phenylbutazone—PTGS2—epithelium—ovarian cancer	0.00755	0.0155	CbGeAlD
Phenylbutazone—PTGS2—uterine cervix—ovarian cancer	0.00749	0.0154	CbGeAlD
Phenylbutazone—PTGS1—endometrium—ovarian cancer	0.00709	0.0146	CbGeAlD
Phenylbutazone—PTGS2—endometrium—ovarian cancer	0.00677	0.0139	CbGeAlD
Phenylbutazone—PTGS1—uterus—ovarian cancer	0.00653	0.0134	CbGeAlD
Phenylbutazone—CYP2C9—female reproductive system—ovarian cancer	0.00643	0.0132	CbGeAlD
Phenylbutazone—PTGS2—uterus—ovarian cancer	0.00624	0.0128	CbGeAlD
Phenylbutazone—PTGS1—female reproductive system—ovarian cancer	0.00587	0.0121	CbGeAlD
Phenylbutazone—PTGS2—female reproductive system—ovarian cancer	0.00561	0.0115	CbGeAlD
Phenylbutazone—PTGS1—female gonad—ovarian cancer	0.00534	0.011	CbGeAlD
Phenylbutazone—PTGS1—vagina—ovarian cancer	0.00531	0.0109	CbGeAlD
Phenylbutazone—PTGS2—bone marrow—ovarian cancer	0.0053	0.0109	CbGeAlD
Phenylbutazone—PTGS2—female gonad—ovarian cancer	0.00511	0.0105	CbGeAlD
Phenylbutazone—PTGS2—vagina—ovarian cancer	0.00508	0.0104	CbGeAlD
Phenylbutazone—CYP3A4—female reproductive system—ovarian cancer	0.0049	0.0101	CbGeAlD
Phenylbutazone—PTGS1—testis—ovarian cancer	0.00474	0.00975	CbGeAlD
Phenylbutazone—PTGS1—lymph node—ovarian cancer	0.00343	0.00707	CbGeAlD
Phenylbutazone—PTGS2—lymph node—ovarian cancer	0.00328	0.00675	CbGeAlD
Phenylbutazone—Protriptyline—ABCB1—ovarian cancer	0.00183	0.27	CrCbGaD
Phenylbutazone—Sulfinpyrazone—ABCB1—ovarian cancer	0.00168	0.247	CrCbGaD
Phenylbutazone—Fentanyl—ABCB1—ovarian cancer	0.000914	0.135	CrCbGaD
Phenylbutazone—Clobazam—ABCB1—ovarian cancer	0.000909	0.134	CrCbGaD
Phenylbutazone—Phenytoin—ABCB1—ovarian cancer	0.000829	0.122	CrCbGaD
Phenylbutazone—Methadone—ABCB1—ovarian cancer	0.000627	0.0923	CrCbGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000619	0.00216	CbGpPWpGaD
Phenylbutazone—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—ovarian cancer	0.000616	0.00215	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—YAP1—ovarian cancer	0.000606	0.00212	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—MYC—ovarian cancer	0.000602	0.00211	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.0006	0.0021	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000598	0.00209	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CHEK2—ovarian cancer	0.000593	0.00207	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—TUBB3—ovarian cancer	0.000591	0.00206	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—FASN—ovarian cancer	0.00059	0.00206	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—ovarian cancer	0.000589	0.00206	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—EGFR—ovarian cancer	0.000589	0.00206	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PARP1—ovarian cancer	0.000588	0.00205	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—SLC2A1—ovarian cancer	0.000561	0.00196	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TLR4—ovarian cancer	0.000559	0.00195	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—KRAS—ovarian cancer	0.000557	0.00195	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA1—ovarian cancer	0.000555	0.00194	CbGpPWpGaD
Phenylbutazone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	0.000528	0.00184	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000527	0.00184	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HSD17B6—ovarian cancer	0.000511	0.00179	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—BRCA2—ovarian cancer	0.000502	0.00175	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000495	0.00173	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—FASN—ovarian cancer	0.000494	0.00173	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—NME2—ovarian cancer	0.000493	0.00172	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CDKN1B—ovarian cancer	0.000486	0.0017	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CCNE1—ovarian cancer	0.000486	0.0017	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ABCB1—ovarian cancer	0.000486	0.0017	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—SLC5A5—ovarian cancer	0.000486	0.0017	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—ovarian cancer	0.000478	0.00167	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PPP2R1A—ovarian cancer	0.000477	0.00167	CbGpPWpGaD
Phenylbutazone—PTGS2—Aryl Hydrocarbon Receptor—HRAS—ovarian cancer	0.000473	0.00165	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000472	0.00165	CbGpPWpGaD
Phenylbutazone—SLC22A11—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000472	0.00165	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—SLC2A1—ovarian cancer	0.000469	0.00164	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—CCND1—ovarian cancer	0.000464	0.00162	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.00046	0.00161	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000456	0.00159	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CYP1B1—ovarian cancer	0.00045	0.00157	CbGpPWpGaD
Phenylbutazone—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	0.000425	0.00149	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000419	0.00147	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000418	0.00146	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CHMP4C—ovarian cancer	0.000409	0.00143	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—NRAS—ovarian cancer	0.0004	0.0014	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PPP2R1A—ovarian cancer	0.000399	0.00139	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000397	0.00139	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	0.000394	0.00138	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—NME2—ovarian cancer	0.000392	0.00137	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	0.000381	0.00133	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CXCL8—ovarian cancer	0.000379	0.00133	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—TERT—ovarian cancer	0.000379	0.00132	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—MYC—ovarian cancer	0.000372	0.0013	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ESR1—ovarian cancer	0.000371	0.0013	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—ABCB1—ovarian cancer	0.000371	0.0013	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CDKN1B—ovarian cancer	0.000371	0.00129	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—TYMS—ovarian cancer	0.000364	0.00127	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CASP3—ovarian cancer	0.000363	0.00127	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL2—ovarian cancer	0.000363	0.00127	CbGpPWpGaD
Phenylbutazone—SLC22A8—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.00036	0.00126	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—BCL9—ovarian cancer	0.000354	0.00124	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—CCND1—ovarian cancer	0.000354	0.00124	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—APC—ovarian cancer	0.000351	0.00122	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CAV1—ovarian cancer	0.00035	0.00122	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—KRAS—ovarian cancer	0.000344	0.0012	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MMP9—ovarian cancer	0.000343	0.0012	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000341	0.00119	CbGpPWpGaD
Phenylbutazone—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	0.00034	0.00119	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.000332	0.00116	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6ST—ovarian cancer	0.000332	0.00116	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	0.000328	0.00115	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—APC—ovarian cancer	0.000319	0.00111	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYTB—ovarian cancer	0.000318	0.00111	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000311	0.00109	CbGpPWpGaD
Phenylbutazone—SLC22A6—Transmembrane transport of small molecules—ABCB1—ovarian cancer	0.000301	0.00105	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—CAV1—ovarian cancer	0.000293	0.00102	CbGpPWpGaD
Phenylbutazone—PTGS2—C-MYB transcription factor network—HRAS—ovarian cancer	0.000292	0.00102	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MAPK3—ovarian cancer	0.000292	0.00102	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MYC—ovarian cancer	0.000284	0.000991	CbGpPWpGaD
Phenylbutazone—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	0.00028	0.00098	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PIK3CD—ovarian cancer	0.00028	0.00098	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	0.00028	0.000979	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPP1CC—ovarian cancer	0.000278	0.000971	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—BRIP1—ovarian cancer	0.000278	0.000971	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—MAPK1—ovarian cancer	0.000277	0.000969	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—EGFR—ovarian cancer	0.000277	0.000969	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	0.000277	0.000967	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—ovarian cancer	0.000272	0.000951	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000271	0.000946	CbGpPWpGaD
Phenylbutazone—PTGS2—Selenium Micronutrient Network—IL6—ovarian cancer	0.00027	0.000942	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CG—ovarian cancer	0.000267	0.000934	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PPP1CC—ovarian cancer	0.000263	0.00092	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—NME2—ovarian cancer	0.000259	0.000906	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYTB—ovarian cancer	0.000252	0.000882	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—ovarian cancer	0.000252	0.000881	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—ERBB2—ovarian cancer	0.000248	0.000866	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—ovarian cancer	0.000247	0.000863	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000247	0.000862	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PIK3CB—ovarian cancer	0.000244	0.000854	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MTOR—ovarian cancer	0.000244	0.000854	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—ovarian cancer	0.00024	0.00084	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—ovarian cancer	0.000238	0.000832	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CD—ovarian cancer	0.000235	0.000821	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—TP53—ovarian cancer	0.000233	0.000814	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—ovarian cancer	0.000232	0.000811	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CDKN1B—ovarian cancer	0.000229	0.000802	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPP1CC—ovarian cancer	0.000221	0.000771	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—BRIP1—ovarian cancer	0.000221	0.000771	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	0.00022	0.000769	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—CTNNB1—ovarian cancer	0.000217	0.000757	CbGpPWpGaD
Phenylbutazone—PTGS2—Spinal Cord Injury—IL6—ovarian cancer	0.000213	0.000745	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PTEN—ovarian cancer	0.000211	0.000738	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—ovarian cancer	0.00021	0.000733	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CB—ovarian cancer	0.000205	0.000715	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000202	0.000707	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HDAC6—ovarian cancer	0.0002	0.000697	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—ovarian cancer	0.000198	0.000693	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—ovarian cancer	0.000193	0.000674	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—STAT3—ovarian cancer	0.000189	0.00066	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—ovarian cancer	0.000189	0.000659	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—ovarian cancer	0.000189	0.000659	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—NRAS—ovarian cancer	0.000188	0.000659	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—YAP1—ovarian cancer	0.000186	0.000651	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000184	0.000644	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MAPK3—ovarian cancer	0.00018	0.000631	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	0.000179	0.000627	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—ovarian cancer	0.000178	0.000623	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PTEN—ovarian cancer	0.000177	0.000618	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MYC—ovarian cancer	0.000176	0.000613	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—XIAP—ovarian cancer	0.000173	0.000605	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—MAPK1—ovarian cancer	0.000172	0.0006	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—EGFR—ovarian cancer	0.000172	0.0006	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—NME2—ovarian cancer	0.000171	0.000598	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SMARCA4—ovarian cancer	0.000169	0.000589	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYTB—ovarian cancer	0.000167	0.000584	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EREG—ovarian cancer	0.000165	0.000575	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—ovarian cancer	0.000164	0.000572	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	0.000163	0.000571	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—KRAS—ovarian cancer	0.000162	0.000567	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000162	0.000566	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000161	0.000562	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—ovarian cancer	0.000158	0.000554	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—FASN—ovarian cancer	0.000152	0.000531	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC5A5—ovarian cancer	0.000149	0.000522	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—PIK3CA—ovarian cancer	0.000149	0.000521	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—YAP1—ovarian cancer	0.000148	0.000517	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	0.000146	0.000512	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—BRIP1—ovarian cancer	0.000146	0.00051	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPP1CC—ovarian cancer	0.000146	0.00051	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—SLC2A1—ovarian cancer	0.000144	0.000504	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—FASN—ovarian cancer	0.000144	0.000503	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PARP1—ovarian cancer	0.000143	0.000501	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000141	0.000494	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CYP1B1—ovarian cancer	0.000138	0.000483	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—HRAS—ovarian cancer	0.000138	0.000482	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—SLC2A1—ovarian cancer	0.000137	0.000478	CbGpPWpGaD
Phenylbutazone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—ovarian cancer	0.000134	0.000467	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—IL6—ovarian cancer	0.000132	0.000461	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	0.000129	0.00045	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—PIK3CA—ovarian cancer	0.000125	0.000436	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PPP2R1A—ovarian cancer	0.000123	0.000429	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	0.000122	0.000427	CbGpPWpGaD
Phenylbutazone—PTGIS—Disease—AKT1—ovarian cancer	0.000122	0.000425	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—FASN—ovarian cancer	0.000121	0.000421	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC5A5—ovarian cancer	0.000119	0.000414	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PPP2R1A—ovarian cancer	0.000116	0.000406	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—SLC2A1—ovarian cancer	0.000115	0.0004	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—ABCB1—ovarian cancer	0.000114	0.000398	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	0.000112	0.000392	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—TYMS—ovarian cancer	0.000112	0.000391	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYTB—ovarian cancer	0.00011	0.000385	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CYP1B1—ovarian cancer	0.00011	0.000384	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	0.000106	0.000372	CbGpPWpGaD
Phenylbutazone—PTGIS—Metabolism—AKT1—ovarian cancer	0.000102	0.000356	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—YAP1—ovarian cancer	9.8e-05	0.000342	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PPP2R1A—ovarian cancer	9.74e-05	0.00034	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	9.69e-05	0.000339	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	9.69e-05	0.000339	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPP1CC—ovarian cancer	9.63e-05	0.000337	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—BRIP1—ovarian cancer	9.63e-05	0.000337	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—TERT—ovarian cancer	9.24e-05	0.000323	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—ABCB1—ovarian cancer	9.04e-05	0.000316	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—CAV1—ovarian cancer	9.02e-05	0.000315	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—TYMS—ovarian cancer	8.88e-05	0.00031	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	8.61e-05	0.000301	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CAV1—ovarian cancer	8.55e-05	0.000299	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	8.52e-05	0.000298	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CG—ovarian cancer	8.21e-05	0.000287	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6ST—ovarian cancer	8.1e-05	0.000283	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—FASN—ovarian cancer	7.99e-05	0.000279	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC5A5—ovarian cancer	7.85e-05	0.000274	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—APC—ovarian cancer	7.78e-05	0.000272	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—SLC2A1—ovarian cancer	7.59e-05	0.000265	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.43e-05	0.00026	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CYP1B1—ovarian cancer	7.27e-05	0.000254	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CD—ovarian cancer	7.22e-05	0.000252	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—CAV1—ovarian cancer	7.16e-05	0.00025	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CD—ovarian cancer	6.84e-05	0.000239	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	6.84e-05	0.000239	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CG—ovarian cancer	6.52e-05	0.000228	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—YAP1—ovarian cancer	6.46e-05	0.000226	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	6.45e-05	0.000225	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.42e-05	0.000224	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CB—ovarian cancer	6.29e-05	0.00022	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—ERBB2—ovarian cancer	6.04e-05	0.000211	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—ABCB1—ovarian cancer	5.99e-05	0.000209	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CB—ovarian cancer	5.96e-05	0.000208	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MTOR—ovarian cancer	5.96e-05	0.000208	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—TYMS—ovarian cancer	5.88e-05	0.000206	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CD—ovarian cancer	5.73e-05	0.0002	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CDKN1B—ovarian cancer	5.6e-05	0.000196	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PTEN—ovarian cancer	5.44e-05	0.00019	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—CTNNB1—ovarian cancer	5.29e-05	0.000185	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—FASN—ovarian cancer	5.27e-05	0.000184	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.18e-05	0.000181	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PTEN—ovarian cancer	5.15e-05	0.00018	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5e-05	0.000175	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CB—ovarian cancer	5e-05	0.000175	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CYP1B1—ovarian cancer	4.8e-05	0.000168	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—CAV1—ovarian cancer	4.74e-05	0.000166	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—STAT3—ovarian cancer	4.61e-05	0.000161	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—NRAS—ovarian cancer	4.6e-05	0.000161	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.53e-05	0.000158	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAPK3—ovarian cancer	4.4e-05	0.000154	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CG—ovarian cancer	4.32e-05	0.000151	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PTEN—ovarian cancer	4.32e-05	0.000151	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MYC—ovarian cancer	4.28e-05	0.00015	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.25e-05	0.000149	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—MAPK1—ovarian cancer	4.19e-05	0.000146	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—EGFR—ovarian cancer	4.19e-05	0.000146	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—KRAS—ovarian cancer	3.96e-05	0.000138	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—ABCB1—ovarian cancer	3.95e-05	0.000138	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—TYMS—ovarian cancer	3.88e-05	0.000136	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—PIK3CA—ovarian cancer	3.84e-05	0.000134	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CD—ovarian cancer	3.8e-05	0.000133	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—PIK3CA—ovarian cancer	3.64e-05	0.000127	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—HRAS—ovarian cancer	3.36e-05	0.000118	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CB—ovarian cancer	3.31e-05	0.000116	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—IL6—ovarian cancer	3.22e-05	0.000113	CbGpPWpGaD
Phenylbutazone—PTGS1—Metabolism—AKT1—ovarian cancer	3.13e-05	0.000109	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—CAV1—ovarian cancer	3.13e-05	0.000109	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—PIK3CA—ovarian cancer	3.05e-05	0.000106	CbGpPWpGaD
Phenylbutazone—PTGS2—Disease—AKT1—ovarian cancer	2.97e-05	0.000104	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PTEN—ovarian cancer	2.86e-05	9.99e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CG—ovarian cancer	2.85e-05	9.95e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.5e-05	8.75e-05	CbGpPWpGaD
Phenylbutazone—PTGS2—Metabolism—AKT1—ovarian cancer	2.49e-05	8.69e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.18e-05	7.62e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.02e-05	7.05e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PTEN—ovarian cancer	1.89e-05	6.59e-05	CbGpPWpGaD
Phenylbutazone—CYP2C9—Metabolism—AKT1—ovarian cancer	1.65e-05	5.76e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.33e-05	4.65e-05	CbGpPWpGaD
Phenylbutazone—CYP3A4—Metabolism—AKT1—ovarian cancer	1.09e-05	3.8e-05	CbGpPWpGaD
